Press Releases and Product Information January 25, 2023
advertisement
- US FDA accepts supplemental New Drug Application for Jardiance® for adults with chronic kidney disease
- FDA Approves New Type 2 Diabetes Drug Bexagliflozin
- Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program
- DreaMed Diabetes Deploys Diabetes Data Management and Clinical Decision Support Device Into Patients’ Electronic Medical Records at Yale New Haven Health
- ABBOTT LAUNCHES NEW INTEGRATED DIGITAL SOLUTION FOR PEOPLE WITH DIABETES IN IRELAND
- Tidepool Announces FDA Clearance of Tidepool Loop